Roche to pay rich price for one-drug InterMune
August 24, 2014 at 22:17 PM EDT
Roche — the Swiss parent of Genentech Inc. — will buy Brisbane’s InterMune Inc. for $8.3 billion, according to a deal disclosed Sunday...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.